ECLIPSE 3

Welcome & Introduction - Dr. Paul Lacante (BMS Medical Director)

Mode of Action video dual IO

Dual IO: experience in MESOTHELIOMA - case study (20') plus Q&A (5') - Prof. Dr. Paul Baas

Dual IO: experience in NSCLC - case study (20') plus Q&A (5') - Prof. Dr. Luis Paz-Ares

Meet the Expert: Panel discussion

Meeting close

ONC-BE-2100170

ONC-BE-2100170

S. Peters et al.; Annals of Oncology 2022 (https://doi.org/10.1016/j.annonc.2022.01.074) manuscript published since webinar dd 10Nov2021.

ONC-BE-2100170

Reck et al.; ESMO open 2021 (https://doi.org/10.1016/j.esmoop.2021.100273) manuscript published since webinar dd 10Nov2021.

ONC-BE-2100170

Thoracic Oncologist (MD, PhD), The Netherlands Cancer Institute, Amsterdam, The Netherlands

Thoracic Oncologist (MD, PhD), Hospital Universitario de Madrid, Spain

ONC-BE-2100170

ONC-BE-2100170

S. Peters et al.; Annals of Oncology 2022 (https://doi.org/10.1016/j.annonc.2022.01.074) manuscript published since webinar dd 10Nov2021.

ONC-BE-2100170

Reck et al.; ESMO open 2021 (https://doi.org/10.1016/j.esmoop.2021.100273) manuscript published since webinar dd 10Nov2021.

ONC-BE-2100170